Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer
- Submitting institution
-
University of Keele
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 127
- Type
- D - Journal article
- DOI
-
10.1001/jamaoncol.2019.2526
- Title of journal
- JAMA Oncology
- Article number
- -
- First page
- 1556
- Volume
- 5
- Issue
- 11
- ISSN
- 2374-2437
- Open access status
- Compliant
- Month of publication
- August
- Year of publication
- 2019
- URL
-
https://jamanetwork.com/journals/jamaoncology/fullarticle/2749178
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
31
- Research group(s)
-
3 - Health Services Research
- Citation count
- 17
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to analysis and interpretation of study data. The author critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -